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ABSTRACT
Objectives: To explore the predictors of symptom burden at the end of life.
Design: Observational, secondary analysis of Health and Retirement Study (HRS) data.
Setting: USA.
Participants: Two thousand six hundred four deceased, older adults.
Methods: Multivariate Poisson and logistic regression to explore the relationship between
sociodemographic and clinical factors with symptoms. 
Results: Fatigue, pain, dyspnea, depression, and anorexia were common and severe; 58% of
participants experienced more than 3 of these during their last year of life. Sociodemographic
and clinical factors were associated with the number of symptoms as well as the presence of
pain, depression, and dyspnea alone. Decedents in the highest quartile of net worth had fewer
symptoms (incident rate ratio [IRR] 0.90, confidence interval [CI] 0.85–0.96) and less pain (odds
ratio [OR] 0.66, CI 0.51–0.85) than comparisons did. Patients with cancer experienced more
pain (OR 2.02, CI 1.62–2.53) and depression (OR 1.31, CI 1.07–1.61). Patients experienced more
depression (OR 2.37, CI 1.85–3.03) and dyspnea (OR 1.40, CI 1.09–1.78).
Limitation: Use of proxy reports for primary data.
Conclusion: Older Americans experience a large symptom burden in the last year of life,
largely with treatable symptoms such as pain, dyspnea, and depression. The adequacy of
symptom control relates to clinical factors as well as net worth. This association between
symptoms and wealth suggests that access to health care and other social services beyond




IT IS A SAD REALITY that for most Americans ac-cess to good palliative and hospice care is lim-
ited. A recent national survey on the status of
end-of-life care reported that among all U.S. hos-
pitals only 14% offer palliative care, 23% offer
hospice care, and 42% have comprehensive pain
services.1 While these numbers motivate im-
proving end-of-life care for all, there is good rea-
son to focus special attention upon the plight of
older adults.
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Not only do older adults represent the fastest
growing segment of the U.S. population,2 but
they carry an especially high symptom burden.
Desbiens et al.3 showed that among seriously ill,
hospitalized elders, 50% experience pain in the
year after their hospitalization. Among elders in
nursing homes, the estimates are even higher.4–9
Lynn et al.10 showed that in the last 3 days of life,
40% of elders experience severe pain, 80% severe
fatigue, and 25% moderate dysphoria—higher
levels than those reported among equally sick,
younger patients.11
To date, no study has thoroughly explored the
determinants of symptom burden among older
adults. Studies of predictors of symptom burden
among seriously ill, younger patients have shown
that clinical (e.g., comorbidities, age, cognitive
status, and depression), sociodemographic (e.g.,
caregiver support, gender, and ethnicity), and
systemic factors (e.g., hospital and region) are im-
portant3,12,13 patients’ wishes for comfort care
and their wealth appear not to matter.14 It is un-
clear if these factors would be the same for older
adults. Some factors, such as wealth and care-
giver status, may be more salient to older adults
than to younger ones. To improve the end-of-life
care of the older adults, we need to understand
which mutable factors are associated with the ex-
tent of symptom burden. Thus, we decided to ex-
plore the determinants of symptom burden
among older adults using a large, national data-
base of deceased individuals which included clin-




We used data from the Health and Retirement
Study (HRS), a biennial longitudinal survey of a
nationally representative cohort of U.S. adults
aged 50 or older.15 The HRS interviewed a cohort
of individuals aged 70 or older in 1993, 1995, and
1998. For those respondents who died after these
interviews, data were collected from a proxy
when possible during the HRS 1995, 1998, or 2000
exit interview. A total of 2832 HRS respondents
died between 1993 and 1998. After excluding
decedents who were younger than 70 at the time
of death (29; 1%), lacked age data (35; 1%), or
lacked a proxy interview (164; 6%), we were left
with a study population of 2604 (92%) represent-
ing 7.9 million elderly U.S. residents.
The Health and Retirement Study
The HRS, funded by the National Institute on
Aging and performed by the Institute for Social
Research at the University of Michigan, is de-
signed to provide representative data on the ag-
ing of the U.S. population. HRS questionnaire
topics include: health, cognitive status, retirement
planning, subjective probabilities, family struc-
ture, caregiving, employment status, job de-
mands, disability, and demographics, housing,
income, net worth, health insurance and pension
plans. For more details about HRS sampling and
response rates, data collection procedures, and
measures, see Juster and Suzman,15 and the HRS
web site at www.hrsonline.isr.umich.edu/.
Dependent variables
The HRS asked proxies to report on the dece-
dent’s pain, depression, delirium, dyspnea, fa-
tigue, and anorexia. For pain, proxies were asked
if the decedent, “was often troubled with pain be-
tween the last interview and when he died.” For
all other symptoms, proxies were asked, “Was
there a period of at least 1 month during the last
year of life when he had (this symptom)?” An-
swers to these questions were dichotomized and
used as our outcomes of interest. We took par-
ticular interest in pain, depression, and dyspnea,
because in comparison to other symptoms expe-
rienced at the end of life, they are treatable and
not an inevitable part of the dying process (as fa-
tigue, anorexia, or delirium might be).
In addition, we explored overall symptom bur-
den, defined as the total number of symptoms.
Symptom burden was determined by summing
the number of affirmative answers to the 6 symp-
tom questions. Hence, symptom burden could
range from 0 to 6.
Independent variables
We explored clinical, sociodemographic, and
economic factors. Clinical factors that we consid-
ered included: age (categorized as 70–79, 80–89,
and 90 or older), gender (categorized as male or
female), smoking status (categorized as yes or
no), history of alcohol abuse (categorized as yes
or no), history of cognitive impairment (defined
by “fair” or “poor” memory 1 month prior to
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death as assessed by the proxy respondent), and
chronic conditions (presence of cancer, lung,
heart, or cerebrovascular disease). Sociodemo-
graphic factors that we explored included: 
ethnicity (categorized as white, black, or other),
living arrangement (categorized as married, 
unmarried cohabitating, and unmarried living
alone), and educational attainment (categorized
as no education, less than high school, and high
school and above). Economic variables included
household net worth16 (categorized into quar-
tiles: less than $10,400, $10,400–$70,000, $70,000–
$182,000, and more than $182,000) and Medicare
coverage (categorized as yes or no). Other vari-
ables we considered were geographic region (cat-
egorized as Northeast, Midwest, Southeast, and
West), year of death, and any visit for health care
(defined as any overnight stay at a hospital, nurs-
ing home, or hospice) during the last year of life
(categorized as yes or no).
Analyses
We used Poisson regression to explore the as-
sociation between these factors and total symp-
tom burden (categorized into four mutually ex-
clusive categories: 0, 1–2, 3–4, and 5–6). We used
logistic regression to explore the association be-
tween the independent variables (i.e. clinical, so-
ciodemographic, and economic factors) and the
presence of pain, depression and dyspnea. We ac-
counted for the complex sampling design of the
HRS in our analyses.15,16 All statistical analyses
were performed using STATA 7.0 software (Stata
Corporation, College Station, TX).
Ethical considerations
This study was approved by the Health Sci-
ences Institutional Review Board at the Univer-
sity of Michigan. At the time this study was done,
Drs. Silveira and Langa had no conflicts of inter-
est that may have influenced this work; neither
currently receives industry funding.
RESULTS
Study population
Our final study population consisted of 2604
older adults in the HRS who died between 1993
and 2000 and whose proxies had responded to
exit surveys administered in 1995, 1998, or 2000
(2604 represents 94% of the HRS subjects who
died during our study period). The characteris-
tics of our study population are summarized in
Table 1. Subjects’ ages at the time of death ranged
from 70 to 108, with a median age of 84. The pop-
ulation was mostly female (56%), white (89%),
and married (40%). Subjects came from through-
out the United States: 38% from the Southeast,
25% from the Midwest, 20% from the Northeast,
and 17% from the West. Most, 85%, suffered from
at least one chronic condition including: heart
disease (55%), cognitive impairment (42%), can-
cer (34%), stroke (32%), and lung disease (22%).
Proxies reported that the majority of subjects
had died expectedly (59%) and in hospital (39%)
as opposed to home (29%), nursing home (25%),
or hospice (3%). Most subjects (66%) had visited
a hospital, hospice, or nursing facility sometime
in the last year. Proxy data was obtained an av-
erage of 27 months (standard deviation [SD]3) af-
ter the subject’s death.
Proxy population
Descriptive data on proxies was available only
for 700 proxies who themselves were enrolled in
the study (as spouses). Similar to our subjects,
most proxies were white (89%) and married.
Proxies’ ages ranged from 49 to 94 (with a me-
dian of 70) prior to the death of the subject. Most
were male (73%) and high school educated (67%).
Proxies were interviewed a median of 13 months
after the decedent’s death (SD 8; range, 1–39).
Symptom prevalence and burden
Symptoms were widely prevalent within the
study population (Table 1). Approximately half
of the study population was often troubled by
pain (52%), depression (45%), or dyspnea (47%)
from the time of their last interview and when
he/she died. Among those with pain, proxies re-
ported that most (59%) experienced pain at se-
vere levels. Most subjects experienced one or
more symptoms (90%) with 58% experiencing at
least 3.
Pain was most common among individuals
with cancer (63%), lung disease (58%), and car-
diovascular disease (56%). Depression was most
common among individuals with cognitive im-
pairment (57%). Dyspnea was most common
among those with pulmonary disease (83%).
In a Poisson regression adjusting for the so-
ciodemographic, clinical, and economic variables
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listed above, there was a statistically significant
association between the number of symptoms
and age, net worth, chronic conditions (cancer,
lung disease, heart disease, stroke, and cognitive
impairment), visit for health care, place of death,
alcohol abuse, smoking status, and year of death
(Table 2). Age was inversely related to symptom
burden in a dose-response fashion; subjects in the
80–89 and 90 and older age categories had incre-
mentally fewer symptoms (incident rate ratio
[IRR] 0.94 and 0.83, respectively) relative to those
in the reference age category of 70–79. Similar to
age, net worth was inversely related to symptom
burden; subjects in the two highest quartiles of
net worth had fewer symptoms (IRR 0.91 and
0.90, respectively) relative to those in the lowest
quartile. For example, 25% of those in the lowest
quartile experienced 5–6 symptoms while only
18% and 15% of those in the two highest quar-
tiles did (unadjusted, weighted percentage, p 
0.004). Individuals with each of the five chronic
conditions experienced more symptoms com-
pared to those free of the chronic condition. No-
tably, cognitive impairment had the strongest as-
sociation with symptom burden; those with
cognitive impairment had 43% more symptoms
(IRR 1.43, confidence interval [CI] 1.36–1.50) than
those without. Thirty-one percent of those with
cognitive impairment had 5–6 symptoms, while
only 13% of those with normal cognition did (un-
adjusted, weighted percentage, p  .001)
Pain, depression, and dyspnea
In three multivariate logistic regressions ex-
amining factors associated with pain, depression,
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High school and above 1207 (51)
No high school diploma 1118 (43)
No formal education 208 (7)
Living arrangement
Married 1040 (40)
Unmarried, living alone 968 (38)







Heart problem 1389 (55)
Cognitive impairment 1098 (42)
Cancer 856 (34)
Stroke 816 (32)













Visited a hospital in the last year 1651 (64)









Alcohol use 659 (26)
Tobacco use 304 (12)
Year of death







aThis number represents a weighted percentage.
Variable n (%)a
or dyspnea, there was an inverse and dose-re-
lated relationship between age and presence of
these symptoms (Table 3). For example, the old-
est–old (90 or older) had lower risk for pain (OR
0.69, CI 0.51–0.93), depression (OR 0.48, CI
0.35–0.65), and dyspnea (OR 0.50, CI 0.35–0.70)
compared to younger subjects.
Net worth was associated with pain but not de-
pression or dyspnea. This relationship was in-
verse and dose related as well; decedents in the
highest quartile of net worth had lower risk of
pain (OR 0.66, CI 0.51–0.85) compared to those in
the lowest quartile. The relationship between net
worth and depression and dyspnea followed the
same pattern (inverse and dose related), but was
not statistically significant.
Chronic conditions were associated with all
three symptoms after adjusting for other factors.
Pain was most likely among those with cancer
(OR 2.02, CI 1.62–2.53) and heart disease (OR 1.50,
CI 1.18–1.91). Depression was ubiquitously asso-
ciated with all five chronic conditions; however,
those with cognitive impairment seemed to carry
the greatest risk (OR 2.37, CI 1.85–3.03). Dyspnea
was most likely among subjects with lung disease
(OR 7.66, CI 5.93–9.90), heart disease (OR 2.28, CI
1.86–2.79), and cognitive impairment (OR 1.40, CI
1.09–1.78).
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TABLE 2. FACTORS RELATING TO TOTAL SYMPTOM BURDEN AMONG THE
OLDER ADULTS: RESULTS OF A MULTIVARIATE POISSON REGRESSION
Incident
rate ratio
Factor (IRR) 95% CI
Age 70–79 — —
80–89 0.94 0.89–1.00
90 0.83 0.76–0.90
Gender Female 1.02 0.94–1.01
Ethnicity White — —
Black 0.92 0.84–1.00
Other 1.01 0.84–1.20




Education No formal education — —
Less than high school 1.02 0.90–1.16
High school and above 1.01 0.88–1.16
Living arrangement Living alone — —
Unmarried, cohabitating 1.02 0.95–1.09
Married 0.94 0.89–0.96




Chronic conditions Cancer 1.21 1.16–1.26
Lung disease 1.23 1.16–1.30
Stroke 1.04 1.00–1.09
Heart disease 1.17 1.11–1.24
Cognitive impairment 1.43 1.36–1.50
Healthcare visit 1.29 1.23–1.35
Alcohol use 1.02 1.00–1.04
Tobacco use 0.97 0.95–0.99
Medicare 0.97 0.87–1.09









In this nationally representative sample of more
than 2000 older individuals, we found that older
adults carry a great symptom burden in their last
year of life, largely with symptoms that are
amenable to treatment. Fatigue was the most
prevalent symptom, followed by pain, dyspnea,
anorexia, depression and delirium—at frequencies
greater than those observed among hospice pa-
tients.17 Most older adults experienced multiple
symptoms, with over half experiencing at least 3—
at levels similar to those reported for seriously, ill
hospitalized patients.3,10,11,14 Our findings suggest
that a general population of older adults in their
last year of life suffer as much as do patients whom
we traditionally consider for palliative care, that
is, patients with life-limiting conditions and pa-
tients who are severely ill and hospitalized. Be-
cause our current health system provides pallia-
tive care mostly through hospice and inpatient pal-
liative care services, our health care providers’
radar may be set to miss older adults unless they
carry a life-limiting condition or become hospital-
ized with organ failure. This is concerning because
older adults do not die in patterns that would iden-
tify them for palliative care. Indeed, Lunney et al.18
showed that 47% of older adults Medicare dece-
dents die of frailty (defined as a slow decline that
allows the patient to return home between stays
in the hospital), rather than cancer (22%) or organ
system failure (16%). This may explain why stud-
ies have consistently shown undertreatment of
pain among the older adults.4,13 To provide such
patients with palliative care, we would need to
either consider advanced age a life-limiting con-
dition or trigger palliative care not by condition or
prognosis, but by the presence of symptoms.
It appears that clinical, sociodemographic, and
local health system factors all may play a role in
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TABLE 3. FACTORS RELATING TO PAIN, DEPRESSION, AND DYSPNEA AMONG THE
OLDER ADULTS: RESULTS OF MULTIVARIATE POISSON REGRESSION
OR (95% CI)
Factor Pain Depression Dyspnea
Age 70–79 — — —
80–89 0.94 (0.72–1.21) 0.81 (0.61–1.04) 0.86 (0.69–1.06)
90 0.69 (0.51–0.93) 0.48 (0.35–0.65) 0.50 (0.35–0.70)
Gender Female 1.29 (0.98–1.71) 0.88 (0.67–1.16) 0.99 (0.83–1.18)
Ethnicity White — — —
Black 0.85 (0.60–1.21) 0.86 (0.62–1.19) 0.85 (0.62–1.17)
Other 1.20 (0.61–2.38) 0.89 (0.41–1.92) 0.83 (0.40–1.73)
Region Northeast — — —
Southeast 1.05 (0.81–1.36) 1.02 (0.75–1.38) 1.10 (0.81–1.51)
West 1.08 (0.80–1.46) 1.12 (0.79–1.59) 0.96 (0.56–1.64)
Midwest 1.12 (0.80–1.55) 0.97 (0.69–1.35) 1.02 (0.70–1.48)
Education No formal education — — —
Less than high school 1.00 (0.61–1.63) 1.03 (0.64–1.65) 0.86 (0.55–1.32)
High school and above 0.76 (0.46–1.23) 1.07 (0.68–1.66) 1.02 (0.67–1.76)
Living arrangement Living alone — — —
Unmarried, co-habitating 1.16 (0.90–1.48) 0.92 (0.72–1.18) 1.06 (0.78–1.45)
Married 1.10 (0.61–1.63) 0.76 (0.59–0.97) 0.78 (0.58–1.03)
Net worth $10,400 — — —
$10,400–$70,000 0.99 (0.73–1.34) 0.87 (0.66–1.16) 0.85 (0.63–1.14)
$70,000–$182,000 0.70 (0.53–0.93) 0.75 (0.56–1.00) 0.74 (0.50–1.08)
$182,000 0.66 (0.51–0.85) 0.84 (0.63–1.12) 0.76 (0.55–1.05)
Chronic conditions Cancer 2.02 (1.62–2.53) 1.31 (1.07–1.61) 1.08 (0.89–1.32)
Lung disease 1.12 (0.87–1.45) 1.33 (1.04–1.69) 7.66 (5.93–9.90)
Stroke 1.05 (0.85–1.30) 1.42 (1.13–1.77) 0.94 (0.77–1.15)
Heart disease 1.50 (1.18–1.91) 1.52 (1.21–1.93) 2.28 (1.86–2.79)
Cognitive impairment 0.97 (0.79–1.17) 2.37 (1.85–3.03) 1.40 (1.09–1.78)
Healthcare visit 1.79 (1.47–2.18) 1.47 (1.21–1.79) 1.64 (1.35–2.00)
Alcohol use 1.04 (0.98–1.09) 1.02 (0.96–1.09) 1.01 (0.95–1.08)
Tobacco use 0.88 (0.81–0.95) 0.94 (0.86–1.02) 0.85 (0.79–0.92)
aYear of death and Medicare status were adjusted for and are not shown (neither had a statistically significant 
relationship to the outcome of interest).
OR, odds ratio; CI, confidence interval.
symptom burden. In our study, age, comorbidi-
ties (cancer, pulmonary disease, cardiovascular
disease, and cognitive impairment), visits to a
health care provider, alcohol use, tobacco use,
and net worth were all associated with symptom
burden. Of these relationships, three are unique
to the older adults and worthy of discussion.
We found that the oldest–old had the lowest
risk for overall symptom burden as well as pain,
depression, and dyspnea individually. Other
studies have reported that very advanced age is
associated with less pain19–22; we are the first to
show that this is true for other symptoms as well.
Why is this so? It may be that those who survive
into their 90s are a healthier group overall, one
with a lower disease burden and better functional
status than those who are chronically ill and die
before reaching 90. This phenomenon is unlikely
to be due to a birth cohort effect because it has
been observed across birth cohorts since the
1970s.22 There is the possibility that this finding
is the result of an ascertainment bias, in that prox-
ies may not interpret problems such as depres-
sion and dyspnea in the oldest–old as “symp-
toms” because they assume that these problems
are “part of old age.” Further research is neces-
sary to determine if there are systematic differ-
ences in how proxies interpret and report symp-
toms for the oldest-old, as compared to younger
individuals. Regardless of the explanation, find-
ing that the oldest–old have fewer symptoms
means that using age as a criterion for palliative
care would require that the cut-off be set low, at
age 70 for example, where the specificity might
be poor.
Seniors with cognitive impairment had the
greatest symptom burden, more than seniors
with cancer, pulmonary disease or cardiovascu-
lar disease. This finding is not surprising given
the lower rates of enrollment in hospice for pa-
tients with dementia.23 Another possible expla-
nation is that proxies may over-report symptoms
experienced by cognitively impaired patients;
however, studies show that proxies can accu-
rately report the symptoms of patients with mild
to moderate cognitive impairment—this is not so
when patients have advanced dementia.24
Individuals with cognitive impairment had
greater relative risks for depression and dyspnea,
but not pain. The relationship between depres-
sion and cognitive impairment is well known;25
early stages of Alzheimer’s disease and other de-
mentias frequently involve depressive symp-
toms. Why elders with cognitive impairment
might experience more dyspnea, however, is un-
clear; perhaps the functional decline, decondi-
tioning, and aspiration associated with cognitive
decline increase the risk of dyspnea. That cogni-
tive impairment was not associated with pain
may be due to our method of pain assessment
(i.e., by proxy); however, it is known that cogni-
tively impaired older adults do experience a
moderate decrease in pain in comparison to older
adults who are cognitively intact, even after ac-
counting for the method of assessment.26
Our most unique and sobering finding is that
wealth was a strong predictor of symptom bur-
den in older adults during the last year of life,
even after adjusting for other sociodemographic
variables. Older adults belonging to the two high-
est quartiles of net worth ($70,000–182,000 and
more than $182,000) had 9% and 10% lower risk
(respectively) of high symptom burden (i.e., a
higher number of total symptoms) than did older
adults in the lowest quartile of wealth. When we
examined the relationship between wealth and
pain, older adults belonging to the two highest
quartiles of net worth had 30% and 36% lower
odds of experiencing pain. While the relation-
ships between net worth and depression and dys-
pnea were in the same direction (i.e., wealthier
elders experienced less depression and dyspnea)
these relationships were not statistically signifi-
cant.
How might wealth affect the level symptom
burden among older Americans? Most of our
study population was insured (97% had
Medicare) and most, 66%, saw a healthcare pro-
vider at some point during their last year of life.
What is it about their care that may explain why
symptoms persisted among the less privileged?
We offer some potential explanations: elders of
higher socioeconomic status may (1) express their
symptoms more assertively and demand better
care, (2) have more ready access to goods and ser-
vices above and beyond what insurance provides,
(3) have greater access to social capital (e.g., so-
cial support from family and friends), or (4) re-
side in settings with better quality of care.
Medicare-dependent older adults bear much fi-
nancial responsibility for their care. Many outpa-
tient services, supplies, and medications are not
covered by Medicare and must be paid for out of
pocket, leaving some older adults to prioritize
and limit treatments. Indeed, Steinman et al.27
showed that many older adults, especially those
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with low income, self-limit their medications be-
cause of the high cost of medication. When given
the choice between medications that may prolong
life, devices or services that may prolong inde-
pendence, and those that might make the quality
of life better, some older adults may choose to
sacrifice their comfort. Alternatively, physicians
might make the choice for them when writing
prescriptions. Patients’ general reluctance to take
certain medications with negative stigma, such as
opiates or antidepressants, may make the deci-
sion even clearer.
To break the connection between wealth and
symptom burden we might consider expanding
Medicare’s services to include medications or ex-
panding the criteria for hospice to include older
adults with significant symptom burden, regard-
less of their prognosis. This would enable older
adults to access medications regardless of ability
to pay and would be consistent with CMS’s mis-
sion to “improve access to services for under-
served and vulnerable beneficiary populations,
including eliminating health disparities.”
This study has a number of potential limita-
tions relating to data collection. We relied on ret-
rospective proxy reports for our outcomes of in-
terest, and this raises several concerns: It is
unclear how accurately proxy reports reflect sub-
jects’ actual experiences. Proxy–subject concor-
dance is known to depend on demographics, re-
lationship, caregiver burden, expectations, hopes,
emotions, and coping skills.24 Moreover, prospec-
tive proxy reports are generally more reliable
than retrospective ones, as memories change with
time, and reports of objective symptoms (e.g.,
vomiting and cough) are more reliable than those
of subjective ones (e.g. pain and depression).24
However, our findings are consistent with those
of others who have explored similar questions
but collected data differently.10,13,17,19,20 In addi-
tion, our findings have face validity, that is, pa-
tients with cardiovascular disease experienced
pain and dyspnea, and those with pulmonary dis-
ease experienced dyspnea. Proxy reports of
chronic conditions may not reflect true diagnoses.
When proxies were asked if patients were de-
pressed, it is unclear if an affirmative answer
means the subject felt blue or carried a DSM IV
diagnosis of depression. Except for pain, symp-
toms were measured in only one realm—their
presence, not their severity or their timing. More-
over, we could not ascertain whether and how
symptoms were treated.
These findings demonstrate the need for wide-
spread institution of symptom assessment and
management for older adults throughout all the
health care settings they frequent—hospitals,
clinics, and nursing homes. However, the ulti-
mate success of such programs may be limited by
elders’ ability to pay for goods and services that
are not covered by Medicare. Further research
into the relationship between wealth and symp-
tom burden is necessary to better identify possi-
ble causal mechanisms leading from poverty to
poor symptom control, and appropriate clinical
and public policy interventions to decrease symp-
tom burden at the end of life.
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RELATIONSHIP OF PROXIES TO DECEASED SUBJECTS






Other relative 209 (8.1)
Paid helper/professional 31 (1.2)
APPENDIX B.
HEALTH AND RETIREMENT STUDY EXIT INTERVIEW QUESTIONS
To assess the subject’s pain, proxies were asked: 





9 Refused to answer
We used answers to classify pain into two mutually exclusive categories. A subject was classified as
having “no pain” if the proxy responded with a 5 and “pain” if the proxy responded 1. Other an-
swers were treated as missing values.
To assess the subject’s depression, proxies were asked: 






9 Refused to answer
A subject was classified as having “No Depression” if the proxy responded with a 5 or “Depression”
if the proxy responded with a 1. Other answers were treated as missing values.
To assess the subject’s difficulty breathing, proxies were asked:







9 Refused to answer
A subject was classified as having “No difficulty” if the proxy responded with a 5 and
“Difficulty” if the proxy responded with a 1 or 3. Other answers were treated as missing values.
SYMPTOM BURDEN 837
This article has been cited by:
1. Margaret Quinn Rosenzweig, Theresa Wiehagen, Adam Brufsky, Anne Sillaman, Robert Arnold. 2009. The Unique Perspective
of Illness Among Women With Metastatic Breast Cancer According to Race and Income. Journal of Hospice & Palliative Nursing
11:1, 27-38. [CrossRef]
2. V. Shannon Burkett, Charles S. Cleeland. 2007. Symptom burden in cancer survivorship. Journal of Cancer Survivorship 1:2,
167-175. [CrossRef]
3. Siew Tzuh Tang, Ruth McCorkle. 2006. Reply to Commentary by Dr Peterson and Dr Groenvold. Quality of Life Research 15:3,
407-409. [CrossRef]
4. Robert M. Arnold . 2006. Lessons LearnedLessons Learned. Journal of Palliative Medicine 9:1, 4-6. [Citation] [PDF] [PDF Plus]
